MX2010003568A - Composiciones y metodos para mejorar la funcion cognitiva. - Google Patents

Composiciones y metodos para mejorar la funcion cognitiva.

Info

Publication number
MX2010003568A
MX2010003568A MX2010003568A MX2010003568A MX2010003568A MX 2010003568 A MX2010003568 A MX 2010003568A MX 2010003568 A MX2010003568 A MX 2010003568A MX 2010003568 A MX2010003568 A MX 2010003568A MX 2010003568 A MX2010003568 A MX 2010003568A
Authority
MX
Mexico
Prior art keywords
compositions
preventing
cognitive function
reducing
enhancing cognitive
Prior art date
Application number
MX2010003568A
Other languages
English (en)
Spanish (es)
Inventor
Yuanlong Pan
Mark Waldron
Brian T Larson
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40526561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010003568(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2010003568A publication Critical patent/MX2010003568A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2010003568A 2007-10-04 2008-10-02 Composiciones y metodos para mejorar la funcion cognitiva. MX2010003568A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99766507P 2007-10-04 2007-10-04
PCT/US2008/011424 WO2009045481A1 (en) 2007-10-04 2008-10-02 Compositions and methods for enhancing cognitive function

Publications (1)

Publication Number Publication Date
MX2010003568A true MX2010003568A (es) 2010-04-21

Family

ID=40526561

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003568A MX2010003568A (es) 2007-10-04 2008-10-02 Composiciones y metodos para mejorar la funcion cognitiva.

Country Status (16)

Country Link
US (1) US20100292330A1 (enExample)
EP (1) EP2194781B2 (enExample)
JP (1) JP5931337B2 (enExample)
CN (1) CN101820754A (enExample)
AU (3) AU2008307494B2 (enExample)
BR (1) BRPI0818301B1 (enExample)
CA (1) CA2701179C (enExample)
ES (1) ES2664777T5 (enExample)
HU (1) HUE037628T2 (enExample)
MX (1) MX2010003568A (enExample)
NO (1) NO2194781T3 (enExample)
PL (1) PL2194781T5 (enExample)
RU (1) RU2507742C2 (enExample)
TR (1) TR201807131T4 (enExample)
WO (1) WO2009045481A1 (enExample)
ZA (1) ZA201003084B (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1648952T3 (en) 2003-06-03 2018-05-28 The Us Gov As Represented By The Department Of Health And Human Services Dietary supplements and therapeutic compositions comprising (R) -3-hydroxybutyrate derivatives
CA2709660C (en) 2008-01-04 2018-06-05 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
WO2010138869A1 (en) 2009-05-29 2010-12-02 The Trustees Of Columbia University In The City Of New York Modulation of phospholipase d for the treatment of neurodegenerative disorders
EP2464350B1 (en) 2009-09-11 2016-08-24 Nestec S.A. Compositions and methods for enhancing cognitive and related functions in animals
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
EP2621503B1 (en) * 2010-09-29 2017-11-01 Orkla Foods Sverige AB Use of a food product comprising viscous fibres which has a beneficial effect on cognitive performance.
JP2014504605A (ja) 2011-01-25 2014-02-24 ネステク ソシエテ アノニム 動物の視覚系の劣化を治療、緩和又は予防するための方法及び組成物
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
JP2014508166A (ja) 2011-03-17 2014-04-03 トランスダーマル バイオテクノロジ インコーポレーテッド 局所的一酸化窒素システム及びその使用方法
EP2685987B1 (en) * 2011-03-18 2019-04-24 Nestec S.A. Compositions and methods useful for ameliorating age related maladies
BR112013028759A2 (pt) * 2011-05-10 2016-08-09 Nestec Sa métodos e composições para conservar a massa magra do corpo durante a perda de peso
WO2012154711A1 (en) * 2011-05-10 2012-11-15 Nestec S.A. Methods and compositions for promoting lean body mass growth
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US8551532B2 (en) 2011-11-02 2013-10-08 Kuwait University Method of making an anti-inflammatory composition
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
KR101588247B1 (ko) * 2013-04-17 2016-01-25 경희대학교 산학협력단 뇌졸중 또는 퇴행성 뇌질환 예방 또는 치료용 조성물
US20160235102A1 (en) * 2013-09-23 2016-08-18 Almendra Americas, LLC Sweetener composition, sweetener products, and methods of sweetening
CN103609752B (zh) * 2013-12-02 2016-05-25 内蒙古伊利实业集团股份有限公司 一种改善脑部认知功能的组合物及其制备方法与应用
MX2017004662A (es) * 2014-10-10 2017-07-26 Nestec Sa Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.
CN107873101B (zh) * 2014-11-21 2022-01-11 克里斯多夫·M·马蒂 用于对象辨识和评估的成像系统
US9789079B2 (en) * 2014-12-08 2017-10-17 Nestec S.A. Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
US10668041B2 (en) 2014-12-08 2020-06-02 Societe Des Produits Nestle Sa Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
CN107708446A (zh) * 2015-06-22 2018-02-16 雀巢产品技术援助有限公司 用于增强动物体内神经形成的组合物和方法
WO2017093060A1 (en) * 2015-12-04 2017-06-08 Nestec S.A. Method for improving cognition
CN105663109A (zh) * 2015-12-29 2016-06-15 浙江旭晨医药科技有限公司 甘油三酯类化合物在制备治疗神经退行性疾病药物中的应用
GB2547903A (en) * 2016-03-01 2017-09-06 Dodson & Horrell Ltd Antioxidant mix for learning
MX391435B (es) 2016-09-29 2025-03-21 Soc Des Produits Nestle S A Star Acidos grasos omega 3 y colina como neuroprotectores en pacientes sin demencia.
CA3054846A1 (en) * 2017-04-11 2018-10-18 Societe Des Produits Nestle S.A. Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals
CA3081756A1 (en) 2017-11-17 2019-05-23 Hill's Pet Nutrition, Inc. Compositions comprising omega-3 polyunsaturated and medium chain fatty acids
MX2020011923A (es) * 2018-06-07 2021-01-15 Nestle Sa Metodos y composiciones para incrementar los cuerpos cetonicos en animales.
WO2019241728A1 (en) * 2018-06-15 2019-12-19 Youhealth Biotech, Limited Composition and methods for modulation of elovl2
JP7270160B2 (ja) * 2018-08-07 2023-05-10 国立大学法人 香川大学 乳化イサダオイル
MX2021014256A (es) 2019-05-24 2022-01-04 Hills Pet Nutrition Inc Composiciones alimenticias para mascotas que comprenden acido caprilico y acido docosahexaenoico y/o acido eicosapentaenoico para el uso en el tratamiento de la urolitiasis de estruvita.
JP7495985B2 (ja) * 2019-12-19 2024-06-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ペットフード組成物
AU2020410289B2 (en) 2019-12-19 2026-02-05 Societe Des Produits Nestle Sa Compositions and methods for providing a health benefit to a growing animal
CN112662800B (zh) * 2020-12-28 2022-12-20 广西大学 水稻耐冷主效qtl cts12的分子标记引物及其标记方法和应用
CN119344377B (zh) * 2024-12-27 2025-03-25 内蒙古伊利实业集团股份有限公司 一种有助于提升和/或改善个体社会行为的营养组合物及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2018A (en) * 1841-03-26 Joseph francis
US5780039A (en) 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5977138A (en) * 1996-08-15 1999-11-02 Schering Corporation Ether muscarinic antagonists
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US7655423B2 (en) 1999-06-14 2010-02-02 Henry Ford Health System Nitric oxide donors for inducing neurogenesis
IL147112A0 (en) * 1999-06-14 2002-08-14 Ford Henry Health System Nitric oxide donors for inducing neurogenesis
US20070179197A1 (en) * 2000-05-01 2007-08-02 Accera, Inc. Compositions and methods for improving or preserving brain function
US20080009467A1 (en) * 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US20050002992A1 (en) * 2003-06-17 2005-01-06 Mccleary Edward Larry Foods, beverages, condiments, spices and salad dressings with specialized supplements
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
US6967219B2 (en) * 2001-10-12 2005-11-22 Cornell Research Foundation, Inc. Reversing or preventing premature vascular senescence
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030113701A1 (en) * 2001-12-13 2003-06-19 William Gartner Self-scoring method and apparatus for early self-screening of neurological disease
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
US8715717B2 (en) * 2003-09-05 2014-05-06 Hill's Pet Nutrition, Inc. Composition for animal consumption
US9040075B2 (en) * 2003-12-19 2015-05-26 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
US20060002985A1 (en) * 2004-07-02 2006-01-05 Zicker Steven C Compositions and methods for decreasing age-related deterioration in mental activities in companion animals
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
CN1810257A (zh) * 2005-05-26 2006-08-02 钟健琳 活脑素口服液
US20070053955A1 (en) * 2005-08-26 2007-03-08 Nestec S.A. Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
WO2007041418A2 (en) * 2005-09-30 2007-04-12 Nestec S.A. Methods and compositions for improving cognitive function
HUE037129T2 (hu) 2005-12-15 2018-08-28 Nestec Sa Kompozíciók és eljárások agyi funkció megõrzésére
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
WO2009002145A1 (en) † 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
CA2709660C (en) * 2008-01-04 2018-06-05 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions

Also Published As

Publication number Publication date
AU2016202685A1 (en) 2016-05-19
BRPI0818301B1 (pt) 2022-02-15
ES2664777T5 (es) 2021-10-25
ES2664777T3 (es) 2018-04-23
TR201807131T4 (tr) 2018-06-21
EP2194781B2 (en) 2021-03-24
CA2701179C (en) 2021-03-16
EP2194781A1 (en) 2010-06-16
JP2010540636A (ja) 2010-12-24
RU2010117221A (ru) 2011-11-10
RU2507742C2 (ru) 2014-02-27
US20100292330A1 (en) 2010-11-18
HUE037628T2 (hu) 2018-09-28
EP2194781A4 (en) 2011-08-24
AU2016202685B2 (en) 2017-09-21
AU2008307494B2 (en) 2013-09-05
PL2194781T3 (pl) 2018-07-31
CN101820754A (zh) 2010-09-01
AU2008307494A1 (en) 2009-04-09
JP5931337B2 (ja) 2016-06-08
AU2013205916B2 (en) 2016-05-19
CA2701179A1 (en) 2009-04-09
PL2194781T5 (pl) 2021-11-15
ZA201003084B (en) 2011-10-26
WO2009045481A1 (en) 2009-04-09
NO2194781T3 (enExample) 2018-07-21
AU2013205916A1 (en) 2013-06-06
EP2194781B1 (en) 2018-02-21
BRPI0818301A2 (pt) 2014-10-07

Similar Documents

Publication Publication Date Title
MX337760B (es) Composiciones que comprenden acidos grasos no saturados y oxido nitrico liberando compuestos y el uso de los mismos para mejorar las funciones cognocitivas y relacionadas.
WO2011031304A3 (en) Compositions and methods for enhancing cognitive and related functions in animals
MX336435B (es) Acidos grasos poliinsaturados para el tratamiento de demencia y condiciones relacionadas con pre-demencia.
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
EP2120920A4 (en) OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
BR112012001468A2 (pt) óleo ou uma gordura coméstivel desodorizada com níveis baixos de mcdp ligado e processo para fabricação usando um gás inerte
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
EA202191667A1 (ru) Содержащий полиненасыщенные жирные кислоты пищевой ингредиент с улучшенными вкусовыми качествами и способ его получения
PH12020551334A1 (en) Chemical mitigation of african swine fever virus and classical swine fever virus
MX2010002404A (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
MY172372A (en) Compositions and methods for lowering triglycerides
PL1800675T4 (pl) Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
PH12015501572A1 (en) Veterinary supplements
IL183246A0 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
ATE451845T1 (de) Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
EP3789476C0 (en) METHOD FOR PRODUCING VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS MADE FROM NATURAL OILS AND NUTRACEUTICAL COMPOSITIONS OBTAINED.
JP2010540636A5 (enExample)
DE602004018902D1 (de) Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
WO2007070701A3 (en) Compositions and methods for preserving brain function
CL2011000290A1 (es) Método para extraer ácidos grasos poliinsaturados de cadena larga; composición de aceite y su uso en tratamiento cosméticos o terapéuticos.
DK1874917T3 (da) Probiotisk sammensætning, der er egnet til dyr
WO2011133841A3 (en) Intravenous omega-3 fatty acid compositions & method of use
DE602005019717D1 (de) Verfahren zur züchtung eines lipidproduzierenden stamms und nutzung davon
WO2018148071A8 (en) Combination therapy for treating disorders of the ear
ATE510464T1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERBESSERUNG DER FUNKTIONALEN GEFÄßINTEGRITÄT, DES ÜBERLEBENS DER ZELLEN UND DER REDUCTION DER APOPTOSE NACH EINEM ISCHÄMIEANFALL IM GEHIRN

Legal Events

Date Code Title Description
FG Grant or registration